Aspen Seeks Drugs Acquisitions as Overseas Deals Fuel Growth

Updated on
  • South African group looks to expand infant nutrition overseas
  • Shares gain most in almost four months in Johannesburg trading

Aspen Pharmacare Holdings Ltd., Africa’s largest generic-drugs maker, is looking for acquisitions and seeking to expand its infant nutrition business after international sales boosted full-year profit.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.